Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/2012
06/13/2012CN102497872A Inhibitor of inflammatory conditions
06/13/2012CN102488816A Chinese patent drug for insufficiency of kidney-yang
06/13/2012CN102488740A Application of chickpea sprout extracts in medicines for preventing deficiency of estrogen
06/13/2012CN102488210A Genistein hydrogel compound and its preparation method
06/13/2012CN101415419B Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
06/12/2012US8198240 Methods for treatment of headaches by administration of oxytocin
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012048446A8 New use of chemical ingredients in cynomorium as phytoestrogen
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142656 Buccal application system comprising 17a-estradiol
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142641 Targetted drug delivery to the bone
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142592 Nasal calcitonin formulations containing chlorobutanol
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012CA2818495A1 Methods for the treatment of fibromyalgia and chronic fatigue syndrome
06/06/2012EP2459705A1 PRODUCTION OF ß-CELLS
06/06/2012EP2459543A1 Benzo [e][1, 3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
06/06/2012EP2459208A2 Therapeutic agents for reducing parathyroid hormone levels
06/06/2012EP2459203A1 Lactic acid bacteria and bifidobacteria for treating endotoxemia
06/06/2012EP1789433B1 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
06/06/2012EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/06/2012CN1935839B Analogues of GLP-1
06/06/2012CN101087758B Indole derivatives useful as progesterone receptor modulators
06/05/2012US8193415 Plant expressing mammalian β1,4-galactosyltransferase and β1,3-glucuronyltransferase
06/05/2012CA2435375C Mammalian tumor susceptibility gene products and their uses
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012071535A2 Pediatric formulation
05/31/2012US20120136052 Substituted acylanilides and methods of use thereof
05/31/2012US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof
05/31/2012US20120135929 Methods Of Modulating Uric Acid Levels
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135069 Nanonized testosteron formulations for improved bioavailability
05/31/2012CA2818565A1 Pediatric formulation
05/30/2012EP2456451A1 Inhibitor of inflammatory conditions
05/30/2012EP2013185B1 Novel compounds
05/30/2012CN102482318A 异噁唑烷衍生物 Isoxazole derivative
05/30/2012CN102482317A 17-羟基-17-五氟乙基-雌-4,9(10)-二烯-11-芳基衍生物、其制备方法及其用于治疗疾病的用途 17- hydroxy-17-pentafluoroethyl - Estrogen-4,9 (10) - dien-11 aryl derivatives, their preparation and their use for the treatment of diseases
05/30/2012CN102481368A Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
05/30/2012CN102477061A 吡啶雄甾衍生物及其在制备预防和/或治疗前列腺癌药物中的用途 Pyridine-androstene derivatives and their use in the manufacture of prevention and / or treatment of prostate cancer medicament
05/30/2012CN102477033A 苯并噻酚类化合物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Benzothiazole phenolic compounds and their preparation for prevention and / or treatment of osteoporosis, breast cancer medicament for use in
05/30/2012CN102477017A 四氢萘衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Tetrahydronaphthalene derivatives and the prevention and / or treatment of osteoporosis, breast cancer in the manufacture of a medicament
05/30/2012CN102477010A 吲哚衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Indole derivatives and their preparation for prevention and / or use in the treatment of osteoporosis, breast cancer medicament
05/30/2012CN102475837A 一种治疗甲状腺肿大的方剂 A goiter prescription treatment
05/30/2012CN102166326B Preparation method of traditional Chinese medicine for treating liver depression and kidney deficiency type hyperthyroidism
05/30/2012CN101953820B Application of styrene phenol compounds to preparing insulin sensitizer
05/30/2012CN101890125B Medicament for treating hyperthyroidism and preparation method thereof
05/30/2012CN101884769B Traditional Chinese medicine for treating autoimmune thyroiditis and production method
05/30/2012CN101723947B Dipeptidase-IV inhibitor compound
05/30/2012CN101292740B Biological food for accelerating sex hormone secretion in vivo
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2495350C Use of lck inhibitor for treatment of immunologic diseases
05/29/2012CA2448218C Sustained release formulation
05/24/2012WO2012067111A1 PKC-ε ACTIVATOR
05/24/2012US20120130199 Methods for Treating Chronic or Unresolvable Pain and/or Increasing the Pain Threshold in a Subject and Pharmaceutical Compositions for Use Therein
05/24/2012US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129823 Contraception process and administration form for the same
05/24/2012US20120129819 Gel compositions for administration of pharmaceutically active compounds
05/24/2012US20120129812 Novel thyroid hormone beta receptor agonist
05/24/2012US20120129783 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
05/24/2012US20120129773 Methods of treating autism and autism spectrum disorders
05/24/2012US20120129767 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
05/24/2012US20120128794 Methods and compositions for the sustained release of chromium
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
05/24/2012CA2818491A1 Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
05/23/2012EP2455371A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
05/23/2012EP2455090A1 Agent for inhibiting increase in postprandial blood insulin level
05/23/2012EP2455089A1 Inhibitor of blood gip level elevation
05/23/2012EP2454282A1 Acylated glucagon analogues
05/23/2012EP2044099B1 Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
05/23/2012EP1325014B1 Gamma-hydroxybutyrate compositions containing carbohydrate carriers
05/23/2012CN102470169A Autoantibody production inhibitor
05/23/2012CN102470159A Composition for the treatment of benign prostate hyperplasia
05/23/2012CN102470152A 用于治疗内毒素血症的乳酸菌和双歧杆菌 For the treatment of endotoxemia lactic acid bacteria and bifidobacteria
05/23/2012CN102470144A 进食后血中胰岛素浓度上升抑制剂 After eating blood insulin concentration increased inhibitors
05/23/2012CN102464702A 制备醋酸亮丙瑞林的方法、产品及用途 Leuprolide preparation methods, products and uses
05/23/2012CN102462736A 肉桂水提取物的制备方法 Cinnamon water extract preparation thereof
05/23/2012CN102462717A 一种西洋参提取物微丸及其制备方法 One kind of American ginseng extract pellets and its preparation method
05/23/2012CN102462715A 一种红参提取物微丸及其制备方法 One kind of red ginseng extract pellets and its preparation method
05/23/2012CN102462688A 木通皂苷d在制备治疗与预防脂肪肝及其相关疾病的药物中的应用 Akeboside d used in the preparation of the treatment and prevention of fatty liver and related diseases in
05/23/2012CN102114185B Medicament for treating insulin resistance of type 2 diabetes
05/23/2012CN102000121B Cordyceps militaris oligopeptide composition as well as preparation method and use thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 290